|
NUP188 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.55000004340178E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.29300003615907E-09 |
| Normal-vs-Stage2 |
8.077200E-03 |
| Normal-vs-Stage3 |
4.26719999999658E-05 |
| Normal-vs-Stage4 |
4.26890000000402E-05 |
| Stage1-vs-Stage2 |
5.036800E-01 |
| Stage1-vs-Stage3 |
4.758400E-01 |
| Stage1-vs-Stage4 |
8.729800E-01 |
| Stage2-vs-Stage3 |
8.897800E-01 |
| Stage2-vs-Stage4 |
5.245600E-01 |
| Stage3-vs-Stage4 |
5.148800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.19330001435713E-09 |
| Normal-vs-AfricanAmerican |
1.496030E-03 |
| Normal-vs-Asian |
4.11919999998567E-06 |
| Caucasian-vs-AfricanAmerican |
5.723000E-01 |
| Caucasian-vs-Asian |
8.008000E-01 |
| AfricanAmerican-vs-Asian |
7.209400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.178450E-04 |
| Normal-vs-Female |
1.09900000211383E-09 |
| Male-vs-Female |
4.584300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.8891999882581E-09 |
| Normal-vs-Age(41-60Yrs) |
5.92390000053733E-07 |
| Normal-vs-Age(61-80Yrs) |
1.396430E-04 |
| Normal-vs-Age(81-100Yrs) |
6.580600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.093400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.098200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.216200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.962800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.773230E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.234800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.484400E-01 |
| Classical-VS-Follicular |
1.47659999782945E-08 |
| Classical-VS-Other |
1.142440E-01 |
| Classical-VS-Normal |
6.68687327731732E-12 |
| Tall-VS-Follicular |
1.984010E-03 |
| Tall-VS-Other |
1.578430E-01 |
| Tall-VS-Normal |
2.568700E-04 |
| Follicular-VS-Other |
7.659000E-01 |
| Follicular-VS-Normal |
4.014600E-01 |
| Other-VS-Normal |
3.628800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.18539999999878E-05 |
| Normal-vs-N1 |
1.301690E-03 |
| N0-vs-N1 |
6.516200E-01 |
|
|
